Ida Liu, an 18-year veteran of the bank, did not detail her future. Citi eliminated her post and will instead have four regional private-banking chiefs.

Citi analysts boosted their price target on Akero Therapeutics (NASDAQ:AKRO) shares to $80 from the previous $65, while keeping a Buy rating on the stock. Currently trading at $51.71, the stock has seen remarkable momentum,

Morgan Stanley raised the firm’s price target on Citi (C) to $109 from $104 and keeps an Overweight rating on the shares. Citi delivered a “strong” EPS print, better than expected 2025 ...

JPMorgan Chase, Bank of America, Citi, Goldman Sachs, Morgan Stanley and BlackRock were all asked about how they plan to implement or have implemented hiring or supplier diversity goals.

In a report released today, Keith Horowitz from Citi maintained a Hold rating on Morgan Stanley (MS – Research Report). The company’s shares

Morgan Stanley, a juggernaut in the wealth management industry, has been repeatedly ahead of its peers when it comes to crypto.

Bank of America and Morgan Stanley are next up in a series of bank earnings reports due out this week. The firms report fourth-quarter results on Thursday morning. Their competitors—JPMorgan Chase, Wells Fargo,

There were massive winners and massive losers on the ASX in 2024. We bring you 2025 outlooks from three major brokers: Buy, hold or sell?

Morgan Stanley turned in $3.7 billion of profit in the fourth quarter, up 147% from a year earlier and exceeding analysts’ estimates of $2.7 billion. The New York-based investment bank posted ...

Sweetgreen (SG) is sinking 6.6% today after Morgan Stanley analyst Brian Harbour significantly reduced his price target on SG stock.

Seagate Technology shares jumped Wednesday as analysts raised their price targets for the data storage provider's stock after the company's quarterly results topped estimates.

Leading fintech firm Pine Labs is gearing up to file its initial public offering (IPO) documents by mid-February. The company had recently completed the process of shifting its base from Singapore to India. The strategic move comes as part of Pine Labs's plan to tap into the Indian capital market at the earliest and go public by August.